LabCorp
LH
#793
Rank
NZ$54.36 B
Marketcap
NZ$669.55
Share price
-0.51%
Change (1 day)
44.28%
Change (1 year)
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.

EPS for LabCorp (LH)

EPS in 2026 (TTM): NZ$21.51

According to LabCorp's latest financial reports the company's current EPS (TTM) is NZ$22.27. In 2025 the company made an earnings per share (EPS) of NZ$19.11 an increase over its 2024 EPS that were of NZ$16.14.

EPS history for LabCorp from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$21.5112.53%
2025NZ$19.1118.45%
2024NZ$16.1489.15%
2023NZ$8.53-66.26%
2022NZ$25.28-43.33%
2021NZ$44.6254.11%
2020NZ$28.9589.43%
2019NZ$15.28-3.33%
2018NZ$15.81-29.7%
2017NZ$22.4975.74%
2016NZ$12.8063.19%
2015NZ$7.84-28.4%
2014NZ$10.95-6.13%
2013NZ$11.675.2%
2012NZ$11.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
IDEXX Laboratories
IDXX
NZ$27.08 21.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$18.48-17.03%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$0.45-102.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.60-83.82%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.38-101.71%๐Ÿ‡บ๐Ÿ‡ธ USA